Blonder Tongue Laboratories, Inc. (BDRL)
OTCMKTS
· Delayed Price · Currency is USD
0.0900
+0.0300 (50.00%)
Jan 17, 2025, 4:00 PM EST
BDRL Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '22 Dec 31, 2022 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Revenue | 18.12 | 18.12 | 15.75 | 16.38 | 19.84 | 21.71 | Upgrade
|
| Revenue Growth (YoY) | 14.99% | 14.99% | -3.82% | -17.45% | -8.59% | -6.77% | Upgrade
|
| Cost of Revenue | 12.65 | 12.65 | 9.9 | 13.36 | 16.41 | 13.29 | Upgrade
|
| Gross Profit | 5.46 | 5.46 | 5.86 | 3.02 | 3.43 | 8.42 | Upgrade
|
| Selling, General & Admin | 5.82 | 5.82 | 6.23 | 7.61 | 8.01 | 6.7 | Upgrade
|
| Research & Development | 1.78 | 1.78 | 2.59 | 2.52 | 3.07 | 2.58 | Upgrade
|
| Operating Expenses | 7.59 | 7.59 | 8.82 | 10.13 | 11.07 | 9.27 | Upgrade
|
| Operating Income | -2.13 | -2.13 | -2.96 | -7.11 | -7.64 | -0.85 | Upgrade
|
| Interest Expense | -0.79 | -0.79 | -0.51 | -0.35 | -0.26 | -0.56 | Upgrade
|
| EBT Excluding Unusual Items | -2.92 | -2.92 | -3.47 | -7.46 | -7.9 | -1.42 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 7.18 | - | Upgrade
|
| Other Unusual Items | - | - | 3.57 | - | - | - | Upgrade
|
| Pretax Income | -2.92 | -2.92 | 0.1 | -7.46 | -0.73 | -1.42 | Upgrade
|
| Income Tax Expense | - | - | 0.02 | 0.02 | 0.02 | -0.08 | Upgrade
|
| Net Income | -2.92 | -2.92 | 0.08 | -7.47 | -0.74 | -1.34 | Upgrade
|
| Net Income to Common | -2.92 | -2.92 | 0.08 | -7.47 | -0.74 | -1.34 | Upgrade
|
| Shares Outstanding (Basic) | 13 | 13 | 12 | 10 | 10 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 13 | 13 | 12 | 10 | 10 | 9 | Upgrade
|
| Shares Change (YoY) | 9.30% | 9.30% | 22.76% | 3.07% | 7.91% | 8.67% | Upgrade
|
| EPS (Basic) | -0.22 | -0.22 | 0.01 | -0.76 | -0.08 | -0.15 | Upgrade
|
| EPS (Diluted) | -0.22 | -0.22 | 0.01 | -0.76 | -0.08 | -0.15 | Upgrade
|
| Free Cash Flow | -1.43 | -1.43 | -1.2 | -3.38 | -6.8 | 0.51 | Upgrade
|
| Free Cash Flow Per Share | -0.11 | -0.11 | -0.10 | -0.34 | -0.71 | 0.06 | Upgrade
|
| Gross Margin | 30.16% | 30.16% | 37.18% | 18.43% | 17.29% | 38.78% | Upgrade
|
| Operating Margin | -11.76% | -11.76% | -18.79% | -43.43% | -38.51% | -3.93% | Upgrade
|
| Profit Margin | -16.12% | -16.12% | 0.53% | -45.63% | -3.74% | -6.17% | Upgrade
|
| Free Cash Flow Margin | -7.89% | -7.89% | -7.60% | -20.62% | -34.28% | 2.33% | Upgrade
|
| EBITDA | -2.01 | -2.01 | -2.62 | -6.78 | -7.25 | -0.33 | Upgrade
|
| EBITDA Margin | -11.07% | -11.07% | -16.63% | -41.41% | -36.56% | -1.53% | Upgrade
|
| D&A For EBITDA | 0.13 | 0.13 | 0.34 | 0.33 | 0.39 | 0.52 | Upgrade
|
| EBIT | -2.13 | -2.13 | -2.96 | -7.11 | -7.64 | -0.85 | Upgrade
|
| EBIT Margin | -11.76% | -11.76% | -18.79% | -43.43% | -38.51% | -3.93% | Upgrade
|
| Effective Tax Rate | - | - | 15.15% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.